SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Jan-24 4:43 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Nov-23 | Option Exercise | 40,000 | $16.00 | $640,000.00 | 100% 0 to 40.0K | |
08-Jan-24 4:43 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Nov-23 | Planned Option Sale | 40,000 | $45.29 | $1,811,600.00 | (100%) 40.0K to 0 | |
12-Jun-23 4:13 PM View: | Keros Therapeutics, Inc. (KROS) | 09-Jun-23 | Option Exercise | 20,000 | $16.00 | $320,000.00 | 100% 0 to 20.0K | |
12-Jun-23 4:13 PM View: | Keros Therapeutics, Inc. (KROS) | 09-Jun-23 | Planned Option Sale | 20,000 | $45.42 | $908,367.00 | (100%) 20.0K to 0 | |
12-Jun-23 4:13 PM View: | Keros Therapeutics, Inc. (KROS) | 08-Jun-23 | Option Exercise | 20,000 | $16.00 | $320,000.00 | 100% 0 to 20.0K | |
12-Jun-23 4:13 PM View: | Keros Therapeutics, Inc. (KROS) | 08-Jun-23 | Planned Option Sale | 20,000 | $47.79 | $955,872.00 | (100%) 20.0K to 0 | |
11-Mar-19 7:19 PM View: | Wave Life Sciences Ltd. (WVE) | 07-Mar-19 | Grant | 13,500 | -- | -- | 86% 15.69K to 29.19K | |
21-Feb-19 7:54 PM View: | Wave Life Sciences Ltd. (WVE) | 19-Feb-19 | Market Sale (Planned) | 1,298 | $36.84 | $47,817.80 | (8%) 16.98K to 15.69K | 76% |
26-Sep-18 6:59 PM View: | Wave Life Sciences Ltd. (WVE) | 24-Sep-18 | Option Exercise | 29,500 | $20.89 | $616,255.00 | 174% 16.98K to 46.48K | |
26-Sep-18 6:59 PM View: | Wave Life Sciences Ltd. (WVE) | 24-Sep-18 | Market Option Sale (Planned) | 29,500 | $55.00 | $1,622,500.00 | (63%) 46.48K to 16.98K | 84% |
21-Feb-18 7:16 PM View: | Wave Life Sciences Ltd. (WVE) | 16-Feb-18 | Market Sale (Planned) | 316 | $51.85 | $16,384.60 | (2%) 17.3K to 16.98K | 83% |
25-Jan-18 8:06 PM View: | Wave Life Sciences Ltd. (WVE) | 23-Jan-18 | Grant | 13,000 | -- | -- | 302% 4.3K to 17.3K | |
27-Jan-17 6:14 PM View: | Wave Life Sciences Ltd. (WVE) | 25-Jan-17 | Grant | 4,300 | -- | -- | 100% 0 to 4.3K |